395 related articles for article (PubMed ID: 33914385)
1. Detection of HIV mRNA in routine liquid-based cytology specimens of HIV-infected women.
Brito MJ; Quintas A; Sequeira P; Alves AT; Martins C; Félix A
Cytopathology; 2021 Sep; 32(5):640-645. PubMed ID: 33914385
[TBL] [Abstract][Full Text] [Related]
2. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
3. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype.
Gu L; Hong Z; Gao H; Qiu L; Di W
Cytopathology; 2019 Jul; 30(4):419-425. PubMed ID: 31069857
[TBL] [Abstract][Full Text] [Related]
4. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
5. HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART.
Madeddu G; Mameli G; Capobianco G; Babudieri S; Maida I; Bagella P; Rocca G; Cherchi PL; Sechi LA; Zanetti S; Nunnari G; Dessole S; Mura MS
Eur Rev Med Pharmacol Sci; 2014; 18(8):1277-85. PubMed ID: 24817305
[TBL] [Abstract][Full Text] [Related]
6. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
7. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
[TBL] [Abstract][Full Text] [Related]
8. Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital.
Muangto T; Chanthasenanont A; Lertvutivivat S; Nanthakomon T; Pongrojpaw D; Bhamarapravatana K; Suwannarurk K
Asian Pac J Cancer Prev; 2016; 17(9):4409-4413. PubMed ID: 27797253
[TBL] [Abstract][Full Text] [Related]
9. Team Reading (Peer Review) of Suspicious/Positive Slides for Continuous Quality Improvement in Cervical-Vaginal Cytology: A Comparison between Methods and Indicators.
Placidi A; Capparucci P; Di Luzio A; Manca G; Mania E; Filippini T; Giorgi Rossi P
Acta Cytol; 2016; 60(5):458-464. PubMed ID: 27504992
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
Shen-Gunther J; Wang CM; Poage GM; Lin CL; Perez L; Banks NA; Huang TH
Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839
[TBL] [Abstract][Full Text] [Related]
11. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
12. Benefit of double-reading cytology smears as a triage strategy among high-risk human papillomavirus-positive women in Mexico.
Ramírez-Palacios P; Chen A; Flores YN; Crespi CM; Lazcano-Ponce E; Alvarez-Escobedo D; Torres-Ibarra L; Rivera-Paredez B; León-Maldonado L; Hernández-López R; Mendiola-Pastrana IR; Méndez-Hernández P; Cuzick J; Carmona E; Figueroa H; Montiel-Cordero F; Meneses-León J; Rao J; Salmerón J;
Cancer Cytopathol; 2020 Oct; 128(10):715-724. PubMed ID: 32520446
[TBL] [Abstract][Full Text] [Related]
13. Rescreening of high-risk HPV positive Papanicolaou tests initially screened as negative is a low yield procedure in the era of HPV genotyping.
Narkcham S; Mody DR; Jones A; Thrall MJ
J Am Soc Cytopathol; 2021; 10(6):558-564. PubMed ID: 34103275
[TBL] [Abstract][Full Text] [Related]
14. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.
Tay SK; Lin LE; Goh RC
Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
16. Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study.
Ebisch RMF; Ketelaars PJW; van der Sanden WMH; Schmeink CE; Lenselink CH; Siebers AG; Massuger LFAG; Melchers WJG; Bekkers RLM
PLoS One; 2018; 13(10):e0206219. PubMed ID: 30356297
[TBL] [Abstract][Full Text] [Related]
17. HPV RNA in situ hybridization can inform cervical cytology-histology correlation.
Coppock JD; Willis BC; Stoler MH; Mills AM
Cancer Cytopathol; 2018 Aug; 126(8):533-540. PubMed ID: 29975461
[TBL] [Abstract][Full Text] [Related]
18. Histologic Outcomes in HPV-Positive and Cervical Cytology- Negative Women - Screening Results in Northern Thailand.
Vijakururote L; Suprasert P; Srisomboon J; Siriaunkgul S; Settakorn J; Rewsuwan S
Asian Pac J Cancer Prev; 2015; 16(16):7271-5. PubMed ID: 26514523
[TBL] [Abstract][Full Text] [Related]
19. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
[TBL] [Abstract][Full Text] [Related]
20. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
Zhang H; Varma KR; Han M; Matsko J; Zhao C
Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]